iShares Biotechnology ETF Rating $210.83 -6.13 (-2.83%) As of 08/20/2026 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.71Holdings in IBB have an aggregate rating of Moderate Buy based on 527 analyst ratings issued in the past year covering 25 companies (65.7% of the portfolio).IBB Aggregate Price Target$210.83High Prediction$210.83Average Prediction$210.83Low Prediction$210.83Holdings in IBB have an aggregate price target of $210.83 and a range of $210.83 to $210.83 covering 25 companies (65.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.76%AMGNAmgen$433.73-2.0%3.8265 of 5 stars2.39$380.43 -12.3%31Trending NewsAnalyst ForecastOptions Volume7.84%VRTXVertex Pharmaceuticals$540.26-2.1%4.2645 of 5 stars2.92$563.50 4.3%24Trending News7.09%GILDGilead Sciences$143.44-2.8%4.2044 of 5 stars2.83$158.04 10.2%29Trending NewsInsider TradeAnalyst Revision6.01%REGNRegeneron Pharmaceuticals$826.64-1.7%3.9237 of 5 stars2.62$801.70 -3.0%26Trending NewsEx-Dividend3.49%ARGXargenex$1,038.12+0.5%4.0211 of 5 stars2.92$1,118.28 7.7%24Trending NewsAnalyst ForecastAnalyst Revision2.91%NTRANatera$324.84-0.1%2.707 of 5 stars2.82$319.38 -1.7%22Positive News2.91%RVMDRevolution Medicines$211.74-1.4%2.3917 of 5 stars2.90$166.33 -21.4%21Positive News2.36%ALNYAlnylam Pharmaceuticals$229.30-5.5%4.8929 of 5 stars2.96$386.62 68.6%24Trending NewsAnalyst Upgrade2.34%BIIBBiogen$214.35-3.3%4.0202 of 5 stars2.58$227.07 5.9%33Positive News2.34%ILMNIllumina$213.24+4.0%2.881 of 5 stars2.47$188.40 -11.6%17Positive NewsInsider TradeGap Down2.02%ONCBeOne Medicines$369.16-2.0%4.0975 of 5 stars3.00$402.14 8.9%171.84%INCYIncyte$127.22-1.0%3.6001 of 5 stars2.48$123.10 -3.2%25Positive NewsAnalyst ForecastInsider Trade1.65%INSMInsmed$125.08-4.3%3.3708 of 5 stars3.00$205.52 64.3%25Positive News1.65%UTHRUnited Therapeutics$521.00-1.5%3.9995 of 5 stars2.85$646.00 24.0%13Insider TradeOptions Volume1.58%MRNAModerna$133.32-23.5%1.6729 of 5 stars2.00$66.25 -50.3%19Trending NewsAnalyst UpgradeOptions VolumeGap DownHigh Trading Volume1.38%ROIVRoivant Sciences$36.84-1.5%1.5247 of 5 stars2.83$35.14 -4.6%12Positive NewsInsider Trade1.24%NBIXNeurocrine Biosciences$152.93-1.7%4.988 of 5 stars2.88$200.86 31.3%241.18%GMABGenmab A/S$33.41-2.1%3.4581 of 5 stars2.85$39.50 18.2%13High Trading Volume1.17%ASNDAscendis Pharma A/S$254.81-1.9%4.4363 of 5 stars3.05$300.33 17.9%19Earnings ReportAnalyst ForecastInsider Trade1.07%BBIOBridgeBio Pharma$82.94-1.2%3.0778 of 5 stars2.83$100.79 21.5%23Insider Trade1.07%EXELExelixis$53.69-1.3%3.3547 of 5 stars2.30$50.07 -6.7%20Analyst Forecast1.05%MEDPMedpace$612.64+0.7%3.7044 of 5 stars2.23$584.18 -4.6%13Positive News0.96%CRLCharles River Laboratories International$292.97+1.0%1.865 of 5 stars2.69$255.65 -12.7%16Insider Trade0.89%ARWRArrowhead Pharmaceuticals$87.47-2.2%2.2711 of 5 stars2.62$97.33 11.3%13Positive NewsInsider Trade0.88%BMRNBioMarin Pharmaceutical$67.68-2.4%4.8182 of 5 stars2.75$88.83 31.2%24Trending NewsAnalyst Forecast This page (NASDAQ:IBB) was last updated on 8/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.